文献速递精神分裂症与精神病性障碍

抗精神病药物在5-HT2A受体的药理学指纹

Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT2A receptor.
PubMed 文献 · Mol Psychiatry · 2024-04-02

该研究采用BRET技术追踪三代共六种抗精神病药物在5-HT2A受体上对5-HT激活的全部信号通路的信号特征,发现药物在Gα亚基和β-arrestin层面呈现通路偏好性,且基于药理学与结构指纹的计算分析可重现临床分类。

要点

  • 利培酮、氯氮平、奥氮平和氟哌啶醇显示G蛋白选择性反向激动活性。
  • 阿立哌唑和卡利拉嗪显示G蛋白选择性部分激动活性。
  • 计算分析支持基于机制聚类重现抗精神病药物临床分类。

核心结论

  • 抗精神病药物在5-HT2A受体上显示先前未识别的通路偏好性,基于药理学与结构指纹的聚类可重现临床分类。

研究设计与样本

  • 采用生物发光共振能量转移(BRET) assay 追踪六种属于三代抗精神病药物在5-HT2A受体上对5-HT激活的全部信号通路的信号特征。

主要发现

  • 利培酮、氯氮平、奥氮平和氟哌啶醇显示G蛋白选择性反向激动活性。
  • 阿立哌唑和卡利拉嗪显示G蛋白选择性部分激动活性。
  • 功能分析确定通路特异性表观解离常数,揭示不同5-HT激活通路的偶联调节能力差异。

临床怎么用

  • 该研究提供功能分类抗精神病药物的新框架,有助于识别更好更安全的神经精神药物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The intricate involvement of the serotonin 5-HT2A receptor (5-HT2AR) both in schizophrenia and in the activity of antipsychotic drugs is widely acknowledged. The currently marketed antipsychotic drugs, although effective in managing the symptoms of schizophrenia to a certain extent, are not without their repertoire of serious side effects. There is a need for better therapeutics to treat schizophrenia for which understanding the mechanism of action of the current antipsychotic drugs is imperative. With bioluminescence resonance energy transfer (BRET) assays, we trace the signaling signature of six antipsychotic drugs belonging to three generations at the 5-HT2AR for the entire spectrum of signaling pathways activated by serotonin (5-HT). The antipsychotic drugs display previously unidentified pathway preference at the level of the individual Gα subunits and β-arrestins. In particular, risperidone, clozapine, olanzapine and haloperidol showed G protein-selective inverse agonist activity. In addition, G protein-selective partial agonism was found for aripiprazole and cariprazine. Pathway-specific apparent dissociation constants determined from functional analyses revealed distinct coupling-modulating capacities of the tested antipsychotics at the different 5-HT-activated pathways. Computational analyses of the pharmacological and structural fingerprints support a mechanistically based clustering that recapitulate the clinical classification (typical/first generation, atypical/second generation, third generation) of the antipsychotic drugs. The study provides a new framework to functionally classify antipsychotics that should represent a useful tool for the identification of better and safer neuropsychiatric drugs and allows formulating hypotheses on the links between specific signaling cascades and in the clinical outcomes of the existing drugs.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Gaitonde SA, Avet C, de la Fuente Revenga M, et al. Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT2A receptor. Mol Psychiatry. 2024. PMID: 38561467. doi:10.1038/s41380-024-02531-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。